瑞典全国样本中物质所致精神病性障碍发病及进展为精神分裂症的预测
该研究在瑞典全国样本中随访7,606例物质所致精神病性障碍患者平均84个月,发现其药物滥用与酒精使用障碍家族风险评分显著升高,而精神病家族风险评分仅轻度升高。进展为精神分裂症的累积风险为11.3%,且精神病家族风险评分而非物质滥用家族风险评分可预测这种进展。
要点
- 物质所致精神病性障碍患者药物滥用和酒精使用障碍家族风险评分显著升高。
- 进展为精神分裂症的累积风险为11.3%,精神病家族风险评分可预测进展。
- 物质所致精神病性障碍后的精神分裂症可能是高危个体的药物促发障碍。
核心结论
- 物质所致精神病性障碍似乎源于物质滥用高家族风险个体的大量药物暴露,其精神病家族风险仅中度升高。
- 精神病家族风险而非物质滥用家族风险可预测从物质所致精神病性障碍进展为精神分裂症。
- 物质所致精神病性障碍后的精神分裂症可能是高危个体的药物促发障碍,而非主要由药物暴露导致的综合征。
研究设计与样本
- 基于瑞典全国医学登记,纳入1997至2015年间登记为物质所致精神病性障碍的个体共7,606例,随访平均84个月。
- 利用医学、犯罪和药房登记中一至三级亲属数据计算非情感性精神病、药物滥用和酒精使用障碍的家族风险评分。
主要发现
- 物质所致精神病性障碍患者药物滥用家族风险评分标准化升高+1.09(95% CI=1.02, 1.15),酒精使用障碍升高+0.98(95% CI=0.93, 1.03),非情感性精神病升高+0.35(95% CI=0.30, 0.41)。
- 进展为精神分裂症的累积风险为11.3%,酒精所致者最低、大麻所致者最高,且由诊断时年龄早、男性、以及后续药物滥用、酒精使用障碍和物质所致精神病性障碍发作登记所预测。
- 风险预测模型发现47%的转化为精神分裂症的个体位于风险最高的20%人群中。
- 药物滥用和酒精使用障碍家族风险评分不能显著区分是否转化为精神分裂症,而非情感性精神病家族风险评分可以区分(0.67, 95% CI=0.40, 0.95 对比 0.33, 95% CI=0.28, 0.39)。
- 非情感性精神病家族风险评分在有或无先前物质所致精神病的精神分裂症个体间无法区分。
临床怎么用
- 对物质所致精神病性障碍患者应评估精神病家族史以识别进展为精神分裂症的高危个体。
- 诊断时年龄早、男性及后续物质滥用或精神病性发作反复登记提示进展风险较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to clarify the etiology of substance-induced psychotic disorder and its progression to schizophrenia in a Swedish national sample. METHODS: Individuals with a registration of substance-induced psychotic disorder between 1997 and 2015 in national medical registries (N=7,606) were followed up for a mean of 84 months. Data from medical, criminal, and pharmacy registries on first-degree through third-degree relatives were used to calculate familial risk scores for nonaffective psychosis, drug abuse, and alcohol use disorder. RESULTS: Individuals with substance-induced psychotic disorder had large elevations in standardized familial risk scores for drug abuse (+1.09, 95% CI=1.02, 1.15) and alcohol use disorder (+0.98, 95% CI=0.93, 1.03) and modest elevations for nonaffective psychosis (+0.35, 95% CI=0.30, 0.41). The cumulative risk for progression to schizophrenia was 11.3%; it was lowest for alcohol-induced and highest for cannabis-induced psychotic disorder, and it was predicted by early age at diagnosis of substance-induced psychotic disorder, male sex, and further registrations for episodes of drug abuse, alcohol use disorder, and substance-induced psychotic disorder. A risk prediction model found that 47% of individuals who converted to schizophrenia were in the upper 20% of risk. Familial risk scores for drug abuse and alcohol use disorder did not significantly discriminate those who converted to schizophrenia from those who did not, while familial risk score for nonaffective psychosis did (0.67, 95% CI=0.40, 0.95, versus 0.33, 95% CI=0.28, 0.39). Familial risk scores for nonaffective psychosis were indistinguishable between individuals with schizophrenia with and without prior substance-induced psychosis. Assignment of early retirement by the Swedish Social Insurance Agency strongly discriminated between individuals with substance-induced psychotic disorder with and without later schizophrenia. CONCLUSIONS: Substance-induced psychotic disorder appears to result from substantial drug exposure in individuals at high familial risk for substance abuse and moderately elevated familial risk for psychosis. Familial risk for psychosis, but not substance abuse, predicts progression from substance-induced psychosis to schizophrenia. Schizophrenia following substance-induced psychosis is likely a drug-precipitated disorder in highly vulnerable individuals, not a syndrome predominantly caused by drug exposure.
引用
- Kendler KS, Ohlsson H, Sundquist J, et al. Prediction of Onset of Substance-Induced Psychotic Disorder and Its Progression to Schizophrenia in a Swedish National Sample. Am J Psychiatry. 2019. PMID: 31055966. doi:10.1176/appi.ajp.2019.18101217
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。